Lista de obras -

A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

artículo científico publicado en 2017

A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score

article

A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design

artículo científico publicado en 2014

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

artículo científico publicado en 2021

Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives

artículo científico publicado en 2016

Assessment of histologic disease activity in Crohn's disease: a systematic review

artículo científico publicado en 2014

Biosimilars in IBD: hope or expectation?: Table 1 ⬇️

artículo científico publicado el 16 de marzo de 2013

Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

artículo científico publicado en 2017

Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort

scientific article published on 17 October 2019

Development and validation of a histological index for UC.

artículo científico publicado en 2015

Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

artículo científico publicado en 2017

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

artículo científico

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

artículo científico publicado en 2020

Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials

artículo científico publicado en 2016

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

artículo científico publicado en 2015

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT

scientific article published on 19 March 2019

Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease

artículo científico publicado en 2016

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

artículo científico publicado en 2013

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

artículo científico publicado en 2016

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease

scientific article published on 15 April 2019

Evolving Concepts in Phases I and II Drug Development for Crohn's Disease

artículo científico publicado en 2016

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review for Development of a Core Outcome Set.

artículo científico publicado en 2018

Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

artículo científico publicado en 2018

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

artículo científico publicado en 2016

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2017

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease

artículo científico publicado en 2015

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease

scientific article published on 29 August 2019

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography

artículo científico publicado en 2018

Reproducibility of histological assessments of disease activity in UC.

artículo científico publicado en 2014

Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

artículo científico publicado en 2017

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

scientific article published on 03 August 2018

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

artículo científico publicado en 2016

Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis

artículo científico publicado en 2017

Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease

artículo científico publicado en 2019

The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews

artículo científico publicado en 2016

The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?

artículo científico publicado en 2017

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

artículo científico publicado en 2014

Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease

artículo científico publicado en 2014

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives

artículo científico

Toward a personalized medicine approach to the management of inflammatory bowel disease

artículo científico

Lista de obras de

A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score

A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressives

Assessment of histologic disease activity in Crohn's disease: a systematic review

Biosimilars in IBD: hope or expectation?: Table 1 ⬇️

Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort

Development and validation of a histological index for UC.

Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT

Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease

Evolving Concepts in Phases I and II Drug Development for Crohn's Disease

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review for Development of a Core Outcome Set.

Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease

Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease

Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease

Reliability of Endoscopic Evaluation of Postoperative Recurrent Crohn's Disease

Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography

Reproducibility of histological assessments of disease activity in UC.

Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis

Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease

The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane Reviews

The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives

Toward a personalized medicine approach to the management of inflammatory bowel disease